about
Construction and analysis of a modular model of caspase activation in apoptosisThe role of receptor internalization in CD95 signaling.Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signalingFAST is a survival protein that senses mitochondrial stress and modulates TIA-1-regulated changes in protein expressionThe enigma of caspase-2: the laymen's viewCentral role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonistABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic developmentA house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell deathMembrane trafficking of death receptors: implications on signallingHost-Cell Survival and Death During Chlamydia InfectionReactive oxygen species, cellular redox systems, and apoptosisSTL-based analysis of TRAIL-induced apoptosis challenges the notion of type I/type II cell line classificationTRAIL-Based High Throughput Screening Reveals a Link between TRAIL-Mediated Apoptosis and Glutathione Reductase, a Key Component of Oxidative Stress ResponseFas Ag-FasL coupling leads to ERK1/2-mediated proliferation of gastric mucosal cellsNuclear and mitochondrial interaction involving mt-Nd2 leads to increased mitochondrial reactive oxygen species productionMolecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012Requirement of biphasic calcium release from the endoplasmic reticulum for Fas-mediated apoptosis.Modulating cell-to-cell variability and sensitivity to death ligands by co-drugging.Cardiac Fas-dependent and mitochondria-dependent apoptosis after chronic cocaine abuseGene transcription profile of the detached retina (An AOS Thesis).A new caspase-8 isoform caspase-8s increased sensitivity to apoptosis in Jurkat cellsEndosomal compartment contributes to the propagation of CD95/Fas-mediated signals in type II cells.Mitochondrial and postmitochondrial survival signaling in cancer.Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth.Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells.Superantigens increase the survival of mice bearing T cell lymphomas by inducing apoptosis of neoplastic cells.A peptide inhibitor of cytochrome c/inositol 1,4,5-trisphosphate receptor binding blocks intrinsic and extrinsic cell death pathways.Autophagy and its link to type II diabetes mellitusProtein Lipidation As a Regulator of Apoptotic Calcium Release: Relevance to Cancer.Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injuryRole of the mitochondria in immune-mediated apoptotic death of the human pancreatic β cell line βLox5.The power and the promise of restimulation-induced cell death in human immune diseases.The molecular regulation of programmed necrotic cell injury.Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease.Selective TRAIL-triggered apoptosis due to overexpression of TRAIL death receptor 5 (DR5) in P-glycoprotein-bearing multidrug resistant CEM/VBL1000 human leukemia cellsAdvances in Viral Vector-Based TRAIL Gene Therapy for Cancer.Diva reduces cell death in response to oxidative stress and cytotoxicity.Activation of caspase-9, but not caspase-2 or caspase-8, is essential for heat-induced apoptosis in Jurkat cells.CD95 is part of a let-7/p53/miR-34 regulatory networkGalectin-3: a potential target for cancer prevention.
P2860
Q21245220-80CFCE1A-053E-413B-994B-A04D2D7EB8D4Q24305510-019CA799-A5F7-4090-9171-4B826AEA09EDQ24328893-F8776BC8-75DC-4767-A3DB-B0C31304D9C5Q24559757-3AC2B74C-5336-493C-8949-CB22DA03ED96Q24595653-EADAC266-9E66-494C-A818-A9DC11883754Q24623979-68CADB74-5477-4B04-A421-0A477BCB7D89Q24653526-21F1F84C-77F5-4060-A5E0-727000CF61B2Q24675372-F8FE776F-5255-49BB-9762-5686F46FD1AFQ26852802-7BCA96DA-C918-4D91-AD77-9D5DAFF8BFB1Q27487010-A506A92B-D2CA-4DF8-B101-718C0C145036Q28393669-AE67D4F9-8A35-4B97-BEB2-C807E1E2F777Q28487858-75FB06B8-EC0E-4307-99FC-C89D752DE857Q28548386-F707E923-CA40-4C2F-B5DA-B03815B5C489Q28566013-49FF691A-FBCF-4BC7-88F7-922BF35AECB1Q28594584-0AD59CC7-5580-4DC9-BF90-32EE29CF0918Q29616161-9E7F23ED-E89C-4893-A09E-102DF01D5E70Q30480565-A35D456B-DB4B-44BB-AE11-D945BF7A15C6Q30544925-175327B2-B797-4A74-8F99-E674E969F671Q33580558-4DA99EE6-45EF-4231-9A34-C82F62B35D34Q33623534-ADECE12F-853C-451D-8145-BBEA4DA4CC99Q33635105-F297A7BA-9F7F-42BC-9CDA-7423875A0979Q33643617-492C424E-2A72-45CB-A998-0B0E019B4949Q33645577-D43886D2-D732-4A7D-9D49-0725B9A5770EQ33705070-396F2D3B-C476-432D-B45C-86489AC113D1Q33723716-69912B61-A1D3-405D-A9E8-1B7C1F8278B5Q33784728-48595215-81ED-4691-8ECE-4CBEA0C6D6FEQ33820142-5AEB2167-7AEE-4EF7-B738-A2C22CDF3CADQ33821526-D26F091B-15F9-43F2-9D30-B707D31BF332Q33849385-1C0C4C3D-9EF6-416A-B2DD-DD8A1F3036B7Q33855218-E9D4076C-12D7-416D-AC01-FF1D76EE023BQ33954575-ED60F85F-772C-4136-BD1A-062A7F4098E7Q34009654-A2D8A712-8757-4A3E-AF2D-4D11094E6EACQ34021860-1B457DD8-1267-41D3-BE17-4172ABC9E0DBQ34142918-4FEC7094-41F7-40CE-A852-E4B0D358F8F9Q34193833-FB1D14E3-A3FF-492F-9C50-81C13152751BQ34384021-82E33C07-0213-45B3-95E9-E62E0F3459D6Q34384826-11143653-1F78-4DEB-91E8-F9DC9F1DF691Q34412566-33355FD6-4006-499A-9A0B-0909B8E0B9CCQ34482626-E1EB4890-7AB4-46DC-A6FA-E8691123D998Q34626339-576F467C-74C0-47D5-A23E-1A176EAF7FEB
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The CD95 type I/type II model.
@ast
The CD95 type I/type II model.
@en
type
label
The CD95 type I/type II model.
@ast
The CD95 type I/type II model.
@en
prefLabel
The CD95 type I/type II model.
@ast
The CD95 type I/type II model.
@en
P1476
The CD95 type I/type II model.
@en
P2093
Bryan C Barnhart
Elizabeth C Alappat
P304
P356
10.1016/S1044-5323(03)00031-9
P577
2003-06-01T00:00:00Z